diazoxide has been researched along with captopril in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (58.06) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 6 (19.35) | 29.6817 |
2010's | 6 (19.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Evered, MD | 1 |
Littler, WA; Smith, SA | 1 |
Bluth, R; Langnickel, R | 1 |
Hughes, JD; Rubin, LJ | 1 |
Rascher, W | 1 |
Evered, MD; Robinson, MM | 1 |
Kincaid-Smith, P | 1 |
Bing, RF; Heagerty, A; Pohl, JE; Russell, GI; Swales, JD; Thurston, H | 1 |
Fischer, E; Siegenthaler, W | 1 |
Anand, MP | 1 |
Brandis, M | 1 |
Lubbe, WF | 1 |
Abe, I; Kawasaki, T; Kawazoe, N; Omae, T | 1 |
Barry, DI; Lassen, NA | 1 |
Song, YC | 1 |
Julius, S; Osterziel, KJ | 1 |
Acconcia, MC; Gaspardone, A; Pannarale, G; Valente, A | 1 |
Philipp, T; Schwietzer, G | 1 |
Kimbrough, CM; Smith, CA; Stocker, SD; Stricker, EM; Sved, AF | 1 |
8 review(s) available for diazoxide and captopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aminorex; Anticoagulants; Autoimmune Diseases; Calcium Channel Blockers; Captopril; Child; Contraceptives, Oral; Cyclooxygenase Inhibitors; Diazoxide; Epoprostenol; Female; Heart Transplantation; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Infant; Liver Diseases; Lung Transplantation; Male; Middle Aged; Nitrates; Thromboembolism | 1986 |
Vasodilator drugs in the treatment of hypertension.
Topics: Calcium Channel Blockers; Captopril; Cardiac Output; Diazoxide; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Minoxidil; Prazosin; Renal Circulation; Vasodilator Agents | 1985 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Cerebral blood flow autoregulation in hypertension and effects of antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cerebrovascular Circulation; Diazoxide; Dihydralazine; Homeostasis; Humans; Hypertension; Hypotension; Rats; Vascular Resistance; Vasodilator Agents | 1984 |
[Early pulmonary hypertension: current therapeutic prospectives].
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Isoproterenol; Nifedipine; Phentolamine; Time Factors | 1982 |
1 trial(s) available for diazoxide and captopril
Article | Year |
---|---|
Treatment of refractory hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diazoxide; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Hypertension, Malignant; Minoxidil | 1982 |
22 other study(ies) available for diazoxide and captopril
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Relationship between thirst and diazoxide-induced hypotension in rats.
Topics: Angiotensin II; Animals; Blood Volume; Captopril; Cardiovascular System; Diazoxide; Drinking; Hypotension; Male; Rats; Rats, Inbred Strains; Thirst | 1990 |
[Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
Topics: Adrenergic alpha-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Coronary Disease; Diazoxide; Drug Tolerance; Enalapril; Hemodynamics; Humans; Hydralazine; Hypertension; Minoxidil; Muscle, Smooth; Nitroglycerin; Vasodilator Agents | 1985 |
[New blood pressure lowering drugs in childhood].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Child; Diazoxide; Drug Therapy, Combination; Humans; Hypertension | 1987 |
Pressor action of intravenous angiotensin II reduces drinking response in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diazoxide; Dose-Response Relationship, Drug; Drinking Behavior; Isoproterenol; Minoxidil; Rats; Thirst; Water-Electrolyte Balance | 1987 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; Minoxidil; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
[Treatment of hypertension in children].
Topics: Adrenergic beta-Antagonists; Age Factors; Captopril; Child; Diazoxide; Diuretics; Humans; Hypertension; Nitroprusside; Vasodilator Agents | 1983 |
Acute electrocardiographic effects of captopril in the initial treatment of malignant or severe hypertension.
Topics: Adult; Blood Pressure; Captopril; Diazoxide; Drug Evaluation; Electrocardiography; Female; Heart Rate; Humans; Hypertension, Malignant; Male; Middle Aged; Proline; Retrospective Studies | 1983 |
[Clinical use of new antihypertensives].
Topics: Alkaloids; Antihypertensive Agents; Benzylisoquinolines; Captopril; Diazoxide; Diterpenes; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin | 1984 |
Vasodilators in the treatment of hypertension.
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hydralazine; Hypertension; Minoxidil; Nitroprusside; Prazosin; Vasodilator Agents | 1982 |
[Treatment of therapy-resistant hypertension].
Topics: Antihypertensive Agents; Captopril; Diazoxide; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Minoxidil | 1982 |
Elevated dietary salt suppresses renin secretion but not thirst evoked by arterial hypotension in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbachol; Cardiotonic Agents; Diazoxide; Diuretics; Dose-Response Relationship, Drug; Drinking Behavior; Hypotension; Isotonic Solutions; Male; Potassium; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Sodium Chloride Symporter Inhibitors; Sodium Chloride, Dietary; Thirst; Time Factors; Vasoconstrictor Agents; Water | 2003 |